← Back to news

G

Google Business, RSS Feed

Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform - Johnson & Johnson

Italian coffee giant Lavazza launches single-serve tablets to make espresso in the U.S. - CNBC

Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate - statnews.com

This agent sent models to meet Jeffrey Epstein. Now he’s trying to explain why. - The Washington Post

Stocks making the biggest moves premarket: Nvidia, Marvell, Flex and more - CNBC

Iran announces 'end of military operations' against Israel, but warns Lebanon strikes could trigger escalation - CNBC

Stock Market Today: Nasdaq Opens Higher; Oil Rallies After Iran-Israel Trade Strikes — Live Update - WSJ

Second Ave Subway Project: Governor Hochul announces next phase of Second Avenue Subway expansion to 125th Street - ABC7 Eyewitness News

Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects - WSJ

S&P 500, Nasdaq futures climb as chip stocks stabilize - Yahoo Finance

4 Changes to Both Medicare Part D and Medicare Advantage Taking Effect in 2026 - AOL.com

Not Your Father’s Country Club: Here Come the Private Racetracks - WSJ

Why tech’s record pullback is just a ‘healthy reset’ for the bull market, according to Morgan Stanley’s top stock-market strategist - MarketWatch

SpaceX Left California. Its IPO Payday Did Not. - Forbes

AI is masking America's "post-literate" workforce - Axios

Smartphones broke dating. AI might finish the job. - vox.com

'We didn’t see this coming': Wall Street eats its forecasts as stocks sell off globally on fear of AI bubble ahead of SpaceX IPO - Fortune

Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. - Barron's

Korean Stocks Tumble as AI Trades Unwind, Threatening Bull Run - Bloomberg.com

Weight loss drug maker sinks 25% after new safety data spooks investors - CNBC

Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success - WSJ

Tumbling tech puts brakes on AI rally, Iran signals end to Israel attacks By Reuters - Investing.com

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial - Nature

Exclusive | Hedge fund titan asks a record $152.5M for his oceanfront Hamptons estate on just 3.4 acres - New York Post

Exclusive | Driverless Trucks Are Here—and They’re Delivering Bags of Doritos - WSJ

Wall Street Strategists See Rally Intact After Healthy Tech Drop - Bloomberg.com

Hustle culture's pricey hangover - Axios

Buy or stand by? What investing pros are saying about investing in SpaceX's IPO. - Business Insider

What's driving Trump to pursue a slice of the AI windfall - Axios

Europe Watches Its Economic Recovery Fade Into the Distance - The New York Times

Two New Studies Ask: Did the iPhone Cause Birthrates to Decline? - The New York Times

Want to know if a data center is being built near you? Search our database of 1,400+ US facilities. - Business Insider

People love working from home. But does it love them back? A new study says no - NPR

Can a vibrating belt fend off bone density loss? - NPR

Here's the Reality That Could Put Fed Chair Kevin Warsh on a Collision Course With Trump - The Motley Fool

Tech stocks gain as Trump mulls government stake in AI companies - Yahoo Finance

Bidding war erupts for world’s oldest bank as Italy’s Intesa gatecrashes BPM offer - CNBC

AMD Commits up to £2 Billion to Accelerate AI Innovation and Research in the United Kingdom - AMD

Inside the Subway Expansion a Century in the Making - The New York Times

AI stocks recover some of last week’s sell-off, while oil prices come off their overnight highs - AP News

Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch - WSJ

South Korea's KOSPI craters over 8% as Fed fears spark tech rout - Reuters

Oil market calm masks a host of unknowns - Reuters

‘Yet another way in which 2026 is looking like 1999’: Top analyst fears bubble popping with investors and Wall Street out over their skis - Fortune

All the Ways Europe Is Ditching American Technology - WIRED

Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics - WSJ

Iranian Crude Offered to China at Discount as Demand Softens - Bloomberg.com

ECB Risks Repeating 2011 Mistake With Rate Hike, Economists Warn - Bloomberg.com

NVIDIA CEO Has Good News for Micron and SanDisk Investors: "The Memory Shortage to Continue for Several Years" - 24/7 Wall St.

NVIDIA CEO Has Good News for Micron and SanDisk Investors: “The Memory Shortage to Continue for Several Years” - Yahoo Finance